Blood banking/immunohematology app Flashcards
Red Blood Cell Membrane
- Lipid bilayer
- Carbohydrate and proteins inserted
- > 300 antigens identified
ABO system
- Precursor H antigen (Bombay)
- Two glycosylated antigens (A and B)
- Four blood types (A, B, AB, and O)
- Naturally-occurring antibodies
Blood Typing
- Forward – patient red blood cells
- Reverse – patient serum
Donors and Recipients
Red Blood Cells
* Type O – universal donor
* Type AB – universal recipient
Plasma
* Type AB – universal recipient
* Type O – universal donor
Rh System
- Antigens – D, c, C, e, E (no d antigen)
- Rh-positive – D antigen present
- Antibodies not naturally-occurring (transfusion or
pregnancy)
Minor Red Blood Cell Antigens
- Kell (K/k)
- Duffy (Fya/Fyb)
- Kidd (Jka/Jkb)
- MNS (M/N; S/s/U)
- Lewis (Lea/Leb)
- Lutheran (Lua/Lub)
- P (P)
- Others
Blood Donation
- Interval - every 56 days (whole blood)
- Age - >16
- Height/Weight – 5’4”/110 pounds
- Feeling well
- Deferral indications
Deferral Indications for blood donation
- Low hemoglobin
- Donor medical history
- Medications
- Sexual history (HIV risk)
- Travel history
- Lifestyle factors
Whole Blood Components
- Packed red blood cells – 42 days, refrigerated
- Platelets – 5 days, room temperature
- Plasma – 1 year, frozen
Apheresis
- Selective removal of one component of blood (e.g.
platelets, plasma, white blood cells, etc.) - Donation versus therapeutic applications
Pre-transfusion Testing
- Blood type of recipient
- Blood type of donor
- Antibody screen on recipient
- Crossmatch
Transfusion Reactions
- Febrile versus non-febrile
- Any febrile reaction is potentially serious
- Immune versus non-immune
- Hemolytic versus non-hemolytic
- Immediate versus delayed
- Mild versus severe
Allergic Reaction
- Allergen in transfused blood reacts with antibodies in
recipient - No fever
- Immediate reaction, non-hemolytic
- Mild, usually local symptoms
- Antihistamines
Febrile Non-Hemolytic Transfusion Reaction
- Cytokines in stored blood
- Fever
- Immediate, non-hemolytic
- Usually mild
- Acetaminophen
Acute Hemolytic Transfusion Reaction
- ABO incompatibility (clerical error)
- Fever/chills, hypotension
- Immediate, intravascular hemolysis
- Severe (abdominal/back pain, respiratory distress,
hemoglobinuria, disseminated intravascular
coagulation, renal failure, circulatory collapse,
“impending doom”, death) - Aggressive medical therapy
Delayed Hemolytic Transfusion Reaction
- Undetectable recipient antibodies
- Fever
- Delayed, hemolytic
- Usually mild (jaundice, decrease in hemoglobin)
- Supportive management
Transfusion-Associated Circulatory Overload
- Volume overload due to transfusion
- No fever
- Immediate
- Moderate-severe (shortness of breath, cough, heart
failure) - Diuretics, respiratory support
Transfusion-Related Acute Lung Injury
- Anti-leukocyte antibodies from donor (especially
female donors), but normovolemic - Fever
- Immediate, non-hemolytic
- Severe (respiratory distress)
- Supportive care, 5-25% mortality
Transfusion-Associated GVH Disease
- Donor lymphocytes (“graft”) proliferate and attack recipient
cells (“host”) - Fever
- Delayed, non-hemolytic
- Severe (skin rash, hepatitis, diarrhea)
- Difficult to manage, >90% mortality
- Prevent by irradiating blood
Post-Transfusion Purpura
- Anti-platelet antibodies (PLA1) in recipient (mainly
females) - Fever
- Delayed, platelet destruction
- May be severe (thrombocytopenia, bleeding)
- Antigen-negative platelets, plasmapheresis
Transfusion-Transmitted Infections
- Overall incidence is very low
- Bacterial infection – 1 in 5,000 to 1/30,000
- HIV – 1 in 2,000,000
- Hepatitis B – 1 in 300,000
- Hepatitis C – 1 in 1,500,000
- West Nile virus – 1 in 350,000
- HTLV-1/2 – 1 in 3,000,000
Selective IgA Deficiency
- Decreased/absent IgA synthesis in recipient (anti-IgA
antibodies react with IgA from donor) - May have fever
- May be immediate
- Most asymptomatic, but risk for anaphylaxis
- IgA-negative donor, wash red blood cells to remove
plasma
Hemolytic Disease of the Newborn
- Incompatibility between mother and baby (mother
lacks an antigen expressed by baby) - Maternal antibodies cross placenta and cause
hemolysis in baby - Most often ABO or Rh
- ABO – usually mild, first pregnancy
- Rh – may be more severe, previous exposure
- Rh Immune globulin prophylaxis
Transfusion Indications
- Clinical evaluation rather than just numbers
- Red blood cells – symptomatic anemia
- 1 gm/dl hemoglobin rise per unit
- Platelets – significant bleeding, thrombocytopenia
- 30-60 x 103 platelet rise per transfusion
- Plasma – significant bleeding, coagulation defect
- 30% factor activity based on body weight and
plasma volume